Antiflammin 1 peptide delivered non-invasively by iontophoresis reduces irritant-induced inflammation in vivo

Experimental Dermatology

Volumn 6, Issue 4, 1997, Pages 181-185

  Mize, Nancy K ^a   Buttery, Margaret ^a   Ruis, Nancy ^a   Leung, Iris ^a   Cormier, Michel ^a   Daddona, Peter ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Antiflammin(s); Chlorpromazine; Contact dermatitis; Inflammation; Iontophoresis; Prostaglandin E2

Indexed keywords

ANTIFLAMMIN; CHLORPROMAZINE; IRRITANT AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHEMA; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; IONTOPHORESIS; NONHUMAN; SKIN IRRITATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHLORPROMAZINE; DERMATITIS, IRRITANT; DINOPROSTONE; DISEASE MODELS, ANIMAL; ERYTHEMA; GUINEA PIGS; IONTOPHORESIS; PEPTIDE FRAGMENTS; SKIN; TIME FACTORS; UTEROGLOBIN;

EID: 0030865960     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1997.tb00203.x     Document Type: Article

References (16)

1. Scheinman R I, Cogswell P C, Lofquist A K, Baldwin Jr A S. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995: 270: 283-286.
2. Auphan N, DiDonato J A, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995: 270: 286-290.
3. Di Rosa M, Flower R J, Hirata F, Parente L, Russo-Marie F. Antiphospholipase proteins. Prostaglandins 1984: 28: 441-142.
4. Miele L, Cordella-Meile E, Facchiano A, Mukherjee A B. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 1988: 335: 726-730.
5. 2 activity by uteroglobin and antiflammin peptides: possible mechanism of action. Life Sci 1991: 48: 453-464.
6. 2. Biochem Pharmacol 1992: 44(3): 519-525.
7. Draize J H, Woodard G, Calvery H O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1994: 82: 377-390.
8. Wilhelm K P, Surber C, Maibach H I. Quantification of sodium lauryl sulfate irritant dermatitis in man: comparison of four techniques: skin color reflectance, transepidermal water loss, laser Doppler flow measurement and visual scores. Arch Dermatol Res 1989: 281: 293-295.
9. Steitz J C, Whitmore C G. Measurement of erythema and tanning responses in human skin using a tri-stimulus color-imeter. Dermatologica 1988: 177: 70.
10. Wilhelm K P, Maibach H I. Skin color reflectance measurements for objective quantification of erythema in human beings. J Am Acad Dermatol 1989: 21: 1306.
11. 2 associated with cutaneous inflammation in vivo, (in press).
12. Lloret S, Moreno J J. Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. Biochem Pharmacol 1995: 50(3): 347-353.
13. Lloret S, Moreno J J. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. Biochem Pharmacol 1992: 44(7): 1437-1441.
14. Ialenti A, Doyle P M, Hardy G N, Simpkin D S E, Di Rosa M. Anti-inflammatory effects of vasocortin and non-apeptide fragments of uteroglobin and lipocortin I (antiflammins). Agents and Actions 1990: 29(1/2): 48-49.
15. Camussi G, Tetta C, Bussolino F, Baglioni C. Anti-in-flammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. J Exp Med 1990: 171: 913-927.
16. Lloret S, Moreno J J. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation. Eur J Pharmacol 1994: 264(3): 379-384.